✦ LIBER ✦

New therapies: plasmapheresis, intravenous immunoglobulin, and monoclonal antibodies

✍ Scribed by Saydain, Ghulam; George, Liziamma; Raoof, Suhail

Book ID: 123448153
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 130 KB
Volume: 18
Category: Article
ISSN: 0749-0704
DOI: 10.1016/S0749-0704(02)00028-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Factors that predict donor-specific anti

Factors that predict donor-specific antibody removal by plasmapheresis and intravenous immunoglobulin

✍ Velta A. Lazda 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 33 KB

ABO-incompatible kidney transplantation

ABO-incompatible kidney transplantation with anti-CD20 monoclonal antibodies, intravenous immunoglobulin and plasmapheresis without splenectomy: a case report

✍ Ryoichi Imamura; Shin Ishiguro; Yi Shi; Yukiomi Namba; Naotsugu Ichimaru; Yoshit 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

Therapy With Plasmapheresis and Intraven

Therapy With Plasmapheresis and Intravenous Immunoglobulin for Acute Humoral Rejection in Kidney Transplantation

✍ M. Ibernón; S. Gil-Vernet; M. Carrera; D. Serón; F. Moreso; O. Bestard; J.M. Cru 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Immunomodulator therapy: Monoclonal anti

Immunomodulator therapy: Monoclonal antibodies, fusion proteins, cytokines, and immunoglobulins

✍ Lee, Susan J.; Chinen, Javier; Kavanaugh, Arthur 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 307 KB

Immunomodulator therapy: Monoclonal anti

Immunomodulator therapy: Monoclonal antibodies, fusion proteins, cytokines, and immunoglobulins

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 33 KB

Intravenous immunoglobulin therapy: New

Intravenous immunoglobulin therapy: New aspects and outlook

✍ Imbach, P. ;Barandun, S. ;Baumgartner, Ch. ;Gaedicke, G. ;Hirt, A. ;Wagner, H. P 📂 Article 📅 1984 🏛 Springer-Verlag ⚖ 220 KB

Experiences gathered while exploring the usefulness of intravenous immunoglobulin for children with idiopathic (immune) thrombocytopenic purpura (ITP) are reviewed in view of further investigations characterizing the effects of IgG i.v. in other immune diseases without detectable antibody deficiency